Författare: Timo Jäger

Volume Editors: Timo Jäger studied biology at the Technical University of Braunschweig, Germany, where he also received his Ph D. He worked as a Postdoc at the German Research Centre for Biotechnology, Braunschweig, and served as Head of Biological Research and Development for MOLISA Gmb H in Magdeburg, Germany. His research centered on the redox metabolism of pathogens, function and catalytic mechanism of peroxiredoxins, target evaluation, characterization, and drug development against infectious diseases, especially tuberculosis and trypanosomiasis. He is currently Managing Director of the Coordination Office of the German Centre for Infection Research DZIF in Braunschweig. Oliver Koch studied pharmacy and computer science at the Philipps-University of Marburg, Germany, where he also received his Ph D in the field of computer-aided drug design. During his post-doctoral studies, he worked as a scientific software engineer at the Cambridge Crystallographic Data Centre (CCDC) in Cambridge, UK, before joining the drug discovery department at MSD Animal Health Innovation Gmb H, Germany. Currently, he is junior research group leader at the faculty of chemistry, TU Dortmund, Germany. His research interests focus on the development and application of computational methods in drug discovery and molecular design. Leopold Flohé studied philosophy, medicine and biochemistry and obtained his MD and the venia legendi for Biochemistry from the University of Tübingen, Germany. He served as Scientific Director for Grünenthal Gmb H in Aachen, the German Biotechnology Centre (HZI) in Braunschweig and Molisa Gmb H in Magdeburg, Germany, while simultaneously teaching at the local universities. His contributions to science were acknowledged with Honorary Degrees from the Universities of Buenos Aires and Montevideo, the Claudius-Galenus-Preis, the Klaus Schwarz Commemorative Medal, the Science and Humanity Price (OCC) and the Trevor Frank Slater Award and Gold Medal (SFRRI). Paul M. Selzer studied biology, parasitology, and biochemistry at the University of Tübingen, Germany, where he also received his Ph D in biochemistry. He spent three years at the Molecular Design Institute and the Parasitology and Tropical Disease Research Laboratory at the University of California, San Francisco. During his career he has worked as a researcher and scientific manager for several pharmaceutical companies, and is currently Director, Molecular Discovery Sciences at MSD Animal Health Innovation Gmb H, Germany. He is also a visiting professor and teacher at the Biochemistry Institute of the University of Tübingen, and an honorary professor of the Department of Infection, Immunity, and Inflammation at the University of Glasgow, UK.